ACS Signs $171 Million HR BPO Contract

DALLAS, Feb. 13 /PRNewswire-FirstCall/ -- Affiliated Computer Services, Inc. (NYSE: ACS) , a premier provider of business process outsourcing and information technology solutions, announced today that it has been awarded a $171 million contract with GlaxoSmithKline (GSK) to provide human resource business process outsourcing (HR BPO) services.

Under terms of the ten-year agreement, ACS will consolidate for GSK a number of services that are currently outsourced to a variety of providers or being delivered within GSK. These include payroll processing and benefits administration for GSK in the US, as well as employee and manager self-service portals and integrated online tools for several HR processes across US and UK businesses.

Currently, ACS provides HR BPO services for a variety of clients supporting more than 3 million people, and delivers services from 135 global locations in 60 countries, supporting 20 languages.

"ACS has been providing services for GlaxoSmithKline in the IT sector since 2003," said Lynn Blodgett, ACS President and Chief Executive Officer, "and the expansion of our partnership into HR BPO services is indicative of their confidence in our capabilities. Our work with GSK, in addition to our existing HR BPO clients, will enable us to break new ground in this fast- growing arena."

ACS, a global FORTUNE 500 company with 58,000 people supporting client operations reaching 100 countries, provides business process outsourcing and information technology solutions to world-class commercial and government clients. The company's Class A common stock trades on the New York Stock Exchange under the symbol "ACS". ACS makes technology work. Visit ACS on the Internet at http://www.acs-inc.com/ .

The statements in this news release that do not directly relate to historical facts constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are subject to numerous risks and uncertainties, many of which are outside the Company's control. As such, no assurance can be given that the actual events and results will not be materially different than the anticipated results described in the forward-looking statements. Factors could cause actual results to differ materially from such forward-looking statements. For a description of these factors, see the Company's prior filings with the Securities and Exchange Commission, including our most recent filing. ACS disclaims any intention or obligation to revise any forward-looking statements, whether as a result of new information, future event, or otherwise.